Lawmakers ask Justice Department to probe Mylan over Medicaid rebates
(By Ed Silverman for ST A T) T hree US senators want the US Department of Justice to investigate whether
Read More
Part D/Prescription Drugs
Behind the grandstanding, Congress may have taken a key step to clarifying drug prices
(By Ed Silverman for ST A T) H eather Bresch was beaten up by Congress 1 last week — and
Read MoreThe Proposed Federal ‘Right-To-Try’ Law Is Not The Answer For Critically Ill Patients
(By Jonathan Friedlaender for Health Affairs Blog, September 27, 2016) Currently, patients have two main options to access experimental therapies
Read MoreElection Buzz: Critics Of Legal Pot Say Addiction Becomes ‘A Disease Of The Family’
(By Kristian Foden-Vencil, Oregon Public Broadcasting and Stina Sieg, KJZZ for Kaiser Health News) If pot laws were colors, a
Read MoreDeadly Opioid Overwhelms First Responders And Crime Labs in Ohio
(By Jake Harper, Side Effects Public Media for Kaiser Health News) Jamie Landrum has been a police officer for two
Read MoreWhen Drug Reviewers Leave The FDA, They Often Work For Pharma
(By Syndney Lupkin for Kaiser Health News) More than a quarter of the Food and Drug Administration employees who approved
Read MoreSenator urges FTC to step up investigation into maker of addiction treatment
(By Ed Silverman for ST A T) A US senator is urging the US Federal Trade Commission to accelerate its
Read MoreDoctors expect to prescribe Sarepta’s DMD drug despite insurance concerns
(By Ed Silverman for ST A T) D efinitive proof may be lacking that the newly approved 1 Duchenne muscular
Read MoreNovel cancer treatment from Kite Pharma notches positive results, but big questions remain
(By Damian Garde for ST A T) A promising new approach to cancer is moving closer to reaching patients, as
Read MoreDiabetes drugs are badly needed, but rarely make it to market
(By Ed Silverman for ST A T) Diabetes 1 may be a widespread disease for which millions of people need
Read More